Key Financial Inc’s Inovio Pharmaceuticals INO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15 Hold
14
﹤0.01% 1349
2026
Q1
$24 Hold
14
﹤0.01% 1385
2025
Q4
$24 Hold
14
﹤0.01% 1431
2025
Q3
$33 Hold
14
﹤0.01% 1448
2025
Q2
$28 Buy
+14
New +$27 ﹤0.01% 1428
2024
Q1
Sell
-15
Closed -$89 1320
2023
Q4
$89 Hold
15
﹤0.01% 1299
2023
Q3
$68 Hold
15
﹤0.01% 1324
2023
Q2
$78 Hold
15
﹤0.01% 1368
2023
Q1
$144 Hold
15
﹤0.01% 1139
2022
Q4
$302 Hold
15
﹤0.01% 1122
2022
Q3
$0 Hold
15
﹤0.01% 1148
2022
Q2
$0 Hold
15
﹤0.01% 1126
2022
Q1
$1K Hold
15
﹤0.01% 1015
2021
Q4
$1K Buy
15
+3
+25% +$240 ﹤0.01% 900
2021
Q3
$1K Buy
12
+2
+20% +$201 ﹤0.01% 872
2021
Q2
$1K Buy
+10
New +$960 ﹤0.01% 823

Other funds holding INO

Key Financial Inc's INO Position: Q2 2026 in Review

Key Financial Inc held its Inovio Pharmaceuticals (INO) position steady in Q2 2026 at 14 shares worth $15. The position accounts for ﹤0.01% of the portfolio, ranked #1349.

Key Financial Inc first reported a position in INO in Q2 2021 and has held it in 16 quarters since. The position peaked at $1K in Q1 2022. 25 funds tracked by Wall St. Rank hold INO as of Q2 2026.

  • Key Financial Inc held 14 shares of Inovio Pharmaceuticals worth $15 as of Q2 2026.
  • Key Financial Inc left its Inovio Pharmaceuticals share count unchanged in Q2 2026.
  • Inovio Pharmaceuticals made up ﹤0.01% of Key Financial Inc's portfolio in Q2 2026, its #1349 holding.
  • Key Financial Inc first reported a position in Inovio Pharmaceuticals in Q2 2021 and has held it in 16 quarters since.
  • Key Financial Inc's Inovio Pharmaceuticals position peaked at $1K in Q1 2022.
  • 25 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2026.

Based on Key Financial Inc's 13F filing for Q2 2026, filed 24 Jul 2026.